Thoratec Corporation  

(Public, NASDAQ:THOR)   Watch this stock  
Find more results for THOR
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week     -
Open     -
Vol. 0.00
Mkt cap     -
P/E 0.00
Div/yield     -
EPS 0.70
Shares 54.80M
Beta     -
Inst. own 94%

Key stats and ratios

Q3 (Jul '15) 2015
Net profit margin 10.29% 10.55%
Operating margin 14.26% 14.64%
EBITD margin - 18.11%
Return on average assets 6.71% 6.48%
Return on average equity 8.02% 7.76%
Employees 954 -
CDP Score - -


6035 Stoneridge Dr
United States - Map
+1-925-8478600 (Phone)
+1-925-8478571 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Thoratec Corporation develops, manufactures and markets medical devices used for mechanical circulatory support for the treatment of heart failure patients. The Company’s products include ventricular assist devices (VADs), such as HeartMate II Left Ventricular Assist System (HeartMate II), HeartMate III Left Ventricular Assist System, Thoratec Paracorporeal Ventricular Assist Device (PVAD) and Thoratec Implantable Ventricular Assist Device (IVAD). For acute circulatory support, the Company’s product lines are CentriMag Acute Circulatory System (CentriMag) and for pediatric patients PediMag/PediVAS Acute Circulatory System (PediMag/PediVAS). HeartMate III, a centrifugal-flow, chronic, left ventricular assist system.